Otrexup - Methotrexate 22.5 mg / .4mL Injection 0.4 mL

Reference details for licensed healthcare facility review and verification.

methotrexate NDC Family 54436-0022 methotrexate 22.5 mg / .4mL

NDC 11	54436-0022-04
Product NDC	54436-0022
Generic Drug Name	methotrexate
Brand Name	Otrexup
Manufacturer	Antares Pharma, Inc.
Strength	22.5 mg / .4mL
Dosage Form	Injection
Drug Type	Subcutaneous
Package Quantity	4 Syringe
Package Description	4 SYRINGE in 1 CARTON (54436-022-04) / .4 mL in 1 SYRINGE (54436-022-02)
Active Ingredients	Methotrexate
Marketing Category	NDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

Reference only: This listing is designed to assist product identification and quote review for licensed healthcare facilities. It does not imply manufacturer endorsement, sponsorship, or direct purchasing status.

Request a Quote Review

Start a quote review for this exact presentation or send a product-specific inquiry. We can combine multiple items into one response for licensed healthcare buyers.

Quote Requests Drug Search

Instructions

Click "Add to Quote Request" to add this item and open your quote request.
Continue browsing and add additional products from other exact NDC detail pages if needed.
Submit one quote request with your organization details and required quantities.
You can review or submit at any time from Quote Request.

Licensing requirement: Quote and fulfillment of prescription pharmaceutical products require valid state and federal licensure and related documentation, where applicable.

Quote Review Form

NDC snapshot

methotrexate 22.5 mg / .4mL Injection is tracked under NDC 54436-0022-04 and rolls up into product family 54436-0022. Use this page to confirm the exact presentation before comparing related family pages or starting a quote review.

Package configuration: 4 Syringe.
Manufacturer: Antares Pharma, Inc..
Dosage form: Injection.
Family size: 3 indexed presentations.

Click a tag to refine the catalog view around this exact presentation.

Review the generic familymethotrexate

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Search DailyMed labelingOpens DailyMed search results.

Alternate presentations in this family

These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.

Otrexup - Methotrexate 22.5 mg / .4mL Injection 0.4 mLNDC 54436-0022-01 | 1 Syringe | Antares Pharma, Inc.Otrexup - Methotrexate 22.5 mg / .4mL Injection 0.4 mLNDC 54436-0022-03 | 1 Syringe | Antares Pharma, Inc.

Otrexup - Methotrexate 22.5 mg / .4mL Injection 0.4 mL, NDC 54436-0022-04, is a Antares Pharma, Inc. 22.5 mg / .4mL injection presentation packaged as 4 Syringe.

NDC search formats

Canonical NDC 11: 54436-0022-04
Digits-only NDC 11: 54436002204
Possible 10-digit display formats: 54436-022-04 (5443602204), 54436-0022-4 (5443600224)

Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.

Helpful product links

Search by brand name: Otrexup
Exact NDC 11: 54436-0022-04
Product family NDC: 54436-0022
Other package sizes in this family: 1 Syringe
Compare related presentations: Otrexup - Methotrexate 22.5 mg / .4mL Injection 0.4 mL, Otrexup - Methotrexate 22.5 mg / .4mL Injection 0.4 mL
VA classification code: AN300
VA classification code description: ANTINEOPLASTICS,ANTIMETABOLITES
CMOP ID: M1137
VUID: 4035633